ArticleBritish journal of cancer2024

DNA ploidy and PTEN as biomarkers for predicting aggressive disease in prostate cancer patients under active surveillance.

Karolina Cyll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.